Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Orion Pharma's Free Cash Flow for the
three
months ended in Mar. 2026 was BDT-44 Mil. Orion Pharma's Revenue for the
three
months ended in Mar. 2026 was BDT1,487 Mil. Therefore, Orion Pharma's FCF Margin % for the quarter that ended in Mar. 2026 was -2.97%.
The historical rank and industry rank for Orion Pharma's FCF Margin % or its related term are showing as below:
DHA:ORIONPHARM'
s FCF Margin % Range Over the Past 10 Years
Min: -15.58 Med: 2.79 Max: 25.18
Current: 10.66
During the past 12 years, the highest FCF Margin % of Orion Pharma was 25.18%. The lowest was -15.58%. And the median was 2.79%.
DHA:ORIONPHARM's FCF Margin % is ranked better than 60.77% of 418
companies
in the Utilities - Independent Power Producers industry
Industry Median: 2.985
vs DHA:ORIONPHARM: 10.66
Orion Pharma FCF Margin % Related Terms
Orion Pharma FCF Margin % Historical Data
* Premium members only.
The historical data trend for Orion Pharma's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DHA:ORIONPHARM vs CEG, VST, NRG: FCF Margin % Comparison
For the Utilities - Independent Power Producers subindustry, Orion Pharma's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Orion Pharma FCF Margin % vs Utilities - Independent Power Producers Industry
For the Utilities - Independent Power Producers industry and Utilities sector, Orion Pharma's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Orion Pharma's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Orion Pharma (DHA:ORIONPHARM) has a FCF Margin % of -2.97% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Orion Pharma and its competitors. According to the industry distribution chart, Orion Pharma ranks #164 out of 418 companies in the Utilities - Independent Power Producers industry, placing it in the top 39.2%.
Is Orion Pharma's FCF Margin % too high?
Orion Pharma's current FCF Margin % is -2.97%. Based on the distribution chart, Orion Pharma ranks #164 out of 418 companies in the Utilities - Independent Power Producers industry, which is above the industry midpoint. Overall, Orion Pharma has a GF Score™ of 72/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Orion Pharma's FCF Margin % compare to CEG and VST?
According to the Utilities - Independent Power Producers industry distribution chart, Orion Pharma ranks #164 out of 418 companies for FCF Margin %. This puts Orion Pharma in the upper half of its industry. The industry median FCF Margin % is 2.99. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for an Utilities - Independent Power Producers company?
The median FCF Margin % among Utilities - Independent Power Producers companies is 2.99, based on 418 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Orion Pharma and its competitors. For the Utilities - Independent Power Producers industry, the median FCF Margin % is 2.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Orion Pharma's current FCF Margin % is -2.97%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Orion Pharma stock overvalued right now?
Based on GuruFocus' analysis, Orion Pharma (DHA:ORIONPHARM) is currently considered Significantly Overvalued. The stock's GF Value™ is BDT20.15, compared to a current price of BDT29.90 — trading 48.4% above its estimated fair value. The current FCF Margin % is -2.97%. Orion Pharma's overall GF Score™ is 72/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Orion Pharma (DHA:ORIONPHARM), the current FCF Margin % is -2.97% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Orion Pharma (DHA:ORIONPHARM) Overvalued in 2026?
Based on GuruFocus' analysis, Orion Pharma stock appears to be overvalued.
The current stock price of BDT29.90 is trading 48.4% above its estimated GF Value™ of BDT20.15.
GuruFocus considers Orion Pharma to be Significantly Overvalued.
Key valuation signals for DHA:ORIONPHARM:
FCF Margin %: -2.97%
GF Value™: BDT20.15 vs. price of BDT29.90 (48.4% above fair value)
No single metric tells the full story. See the DHA:ORIONPHARM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Orion Pharma Ltd is a pharmaceutical company engaged in the creation and discovery, development, manufacturing, and marketing of pharmaceutical products, including vaccines and health-related consumer products. The company produces diversified dosage forms such as tablets, capsules, syrups, solutions, suspensions, powder for suspensions, creams, ointments, and injections under therapeutic categories including cardiovascular, antiulcerant, antiasthmatic, antihistamine, NSAIDs, antibiotic, antifungal, laxatives, anticancer, vitamins, and minerals. In addition, the company is involved in power generation activities and generates maximum revenue from pharmaceutical activities. The group principally carries out its business operations and markets its products in Bangladesh.
72GF Score
Get the complete analysis for DHA:ORIONPHARM
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHA:ORIONPHARM has been successfully added to your 
